121 related articles for article (PubMed ID: 32368)
1. Effects of chlorine substituents on the benzene rings of an analogue of the antipsychotic drug butaclamol on the interaction with dopamine and muscarinic receptors in rat brain.
Pugsley TA; Lippmann W
J Pharm Pharmacol; 1979 Jan; 31(1):47-9. PubMed ID: 32368
[No Abstract] [Full Text] [Related]
2. Neuroleptics related to butaclamol. An investigation of the effects of chlorine substituents on the aromatic rings.
Humber LG; Sideridis N; Asselin AA; Bruderlein FT; Voith K
J Med Chem; 1978 Dec; 21(12):1225-31. PubMed ID: 31480
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific blockade of alpha 2-adrenoceptors by (+)-butaclamol: implications for the characterization of dopamine receptors.
Spedding M; Berg C
J Pharm Pharmacol; 1982 Jan; 34(1):56-8. PubMed ID: 6174723
[No Abstract] [Full Text] [Related]
4. Prenatal neuroleptic exposure alters postnatal striatal cholinergic activity in the rat.
Miller JC; Friedhoff AJ
Dev Neurosci; 1986; 8(2):111-6. PubMed ID: 2427306
[TBL] [Abstract][Full Text] [Related]
5. Effect of structural analogs of butaclamol (a new antipsychotic drug) on striatal homovanillic acid and adenyl cyclase of olfactory tubercle in rats.
Pugsley TA; Merker J; Lippman W
Can J Physiol Pharmacol; 1976 Aug; 54(4):510-5. PubMed ID: 10057
[TBL] [Abstract][Full Text] [Related]
6. The effect of the stereoisomers of butaclamol on neurotensin content in discrete regions of the rat brain.
Bissette G; Dauer WT; Kilts CD; O'Connor L; Nemeroff CB
Neuropsychopharmacology; 1988 Dec; 1(4):329-35. PubMed ID: 2472151
[TBL] [Abstract][Full Text] [Related]
7. Mapping the dopamine receptor. 2. Features derived from modifications in the rings A/B region of the neuroleptic butaclamol.
Philipp AH; Humber LG; Voith K
J Med Chem; 1979 Jul; 22(7):768-73. PubMed ID: 571917
[TBL] [Abstract][Full Text] [Related]
8. [Effect of butaclamol enantiomers on hypothalamic tyrosine hydroxylase in the rat brain].
Mineeva MF; Raevskiĭ KS
Biull Eksp Biol Med; 1984 Oct; 98(10):453-6. PubMed ID: 6208950
[TBL] [Abstract][Full Text] [Related]
9. Use of the butaclamol template in a search for antipsychotic agents with lessened side effects.
Kukla MJ; Bloss JL; Brougham LR
J Med Chem; 1979 Apr; 22(4):401-6. PubMed ID: 34721
[TBL] [Abstract][Full Text] [Related]
10. Stereospecific antagonism by d-butaclamol of dopamine-induced relaxation of the isolated rabbit mesenteric artery.
Brodde OE; Freistühler J; Meyer FJ
J Cardiovasc Pharmacol; 1981; 3(4):828-37. PubMed ID: 6167812
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic activity of four analogs of butaclamol.
Collu R; Bouvier C; Basak A; Dugas H
Pharmacol Res Commun; 1985 Dec; 17(12):1153-7. PubMed ID: 2419927
[TBL] [Abstract][Full Text] [Related]
12. Agents acting on central dopamine receptors.
Kumar N; Jain PC
Prog Drug Res; 1977; 21():409-65. PubMed ID: 22892
[No Abstract] [Full Text] [Related]
13. Histamine-, norepinephrine-, and dopamine-sensitive central adenylate cyclases: effects of chlorpromazine derivatives and butaclamol.
Palmer GC; Wagner HR; Palmer SJ; Manian AA
Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):314-25. PubMed ID: 687395
[TBL] [Abstract][Full Text] [Related]
14. Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatum.
Miller RJ; Horn AS; Iversen LL
J Pharm Pharmacol; 1975 Mar; 27(3):212-3. PubMed ID: 238011
[No Abstract] [Full Text] [Related]
15. [3H]dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration: antagonism by substituted benzamides.
Lin CW; Maayani S; Wilk S
Biochem Pharmacol; 1981 Jun; 30(11):1305-14. PubMed ID: 6168265
[No Abstract] [Full Text] [Related]
16. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
West B; Dannies PS
Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
[TBL] [Abstract][Full Text] [Related]
17. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
Sahakian BJ; Growdon JH; Millington WR; Barr JK; Wurtman RJ
Commun Psychopharmacol; 1978; 2(3):255-62. PubMed ID: 568059
[No Abstract] [Full Text] [Related]
18. Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
Meltzer HY; Paul SM; Fang VS
Psychopharmacology (Berl); 1977 Jan; 51(2):181-3. PubMed ID: 14352
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of chronic agonist administration on mu-opioid receptor- and muscarinic receptor-regulated adenylate cyclase in rat striatal neurons.
Van Vliet BJ; Dotman CH; Wardeh G; Mulder AH; Schoffelmeer AN
Life Sci; 1992; 51(10):PL89-94. PubMed ID: 1325016
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin release from striatal membranes after acute and chronic treatment with butaclamol.
Gnegy ME; Lau YS
Adv Biochem Psychopharmacol; 1980; 24():147-51. PubMed ID: 6157308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
